Potential
dilutive securities are excluded from the calculation of diluted EPS in loss periods as their effect would be anti-dilutive.
Schedule of basic and diluted net loss per share
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
For the Three Months Ended June 30, | | |
For the Nine Months Ended June 30, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Statement of Operations Summary Information: | |
| | | |
| | | |
| | | |
| | |
| Net loss from continued operation | |
$ | (1,615,175 | ) | |
$ | (1,546,288 | ) | |
$ | (2,720,214 | ) | |
$ | (5,505,169 | ) |
| Weighted- average common shares outstanding – basic and diluted | |
| 2,317,314 | | |
| 10,738 | | |
| 949,236 | | |
| 8,543 | |
| Net loss per share, basic and diluted from continued operation | |
$ | (0.70 | ) | |
$ | (144.00 | ) | |
$ | (2.87 | ) | |
$ | (644.40 | ) |
| Net loss from discontinued operation | |
$ | - | | |
$ | - | | |
$ | - | | |
$ | (265,313 | ) |
| Weighted- average common shares outstanding – basic and diluted | |
| - | | |
| 10,738 | | |
| | | |
| 8,543 | |
| Net loss per share, basic and diluted from continued operation | |
$ | - | | |
$ | - | | |
$ | - | | |
$ | (31.05 | ) |
|